๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Activated clotting-time variability in patients undergoing coronary angioplasty

โœ Scribed by Mark F. Warner; M. Shahbaz MIAN; Jose C. Missri

Book ID
112063976
Publisher
John Wiley and Sons
Year
1994
Tongue
English
Weight
361 KB
Volume
17
Category
Article
ISSN
0160-9289

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Percutaneous transluminal coronary angio
Percutaneous transluminal coronary angioplasty: Comparison of arterial vs. venous activated clotting time
โœ Pesola, Gene R. ;Johnson, Audrey ;Pesola, David A. ๐Ÿ“‚ Article ๐Ÿ“… 1996 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 514 KB

When arterial blood samples for activated clotting time (ACT) are difficult to obtain from the arterial sheath during coronary intervention, venous ACT serves as a substitute. Data are lacking on whether arterial and venous ACT are identical and whether one can serve as an effective substitute for t

Activated clotting time differential is
Activated clotting time differential is a superior method of monitoring anticoagulation following coronary angioplasty
โœ Pitney, Mark R. ;Kelly, Selena A. ;Allan, Roger M. ;Giles, Robert W. ;McCredie, ๐Ÿ“‚ Article ๐Ÿ“… 1996 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 548 KB

The standard high-range activated clotting time (sHR ACT) is used to monitor anticoagulation postangioplasty (PTCA), but may be unreliable. We assessed the accuracy of a new method we termed the ACT differential (ACT Diff), obtained by measuring the difference between an sHR ACT and a heparinase ACT